Protara Therapeutics, Inc. — Director's Dealing 2015

Dec 10, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2015-12-08

Reporting Person: Gottlieb Daniel Philip (VP Corporate Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-08	Stock Option (Right to Buy)	$14.70	A	22000	Disposed	2025-12-07	Common Stock, $0.001 par value (22000)	Direct

Footnotes

F1: The options were granted on December 8, 2015 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments.